Implementing CYP2C19 Pharmacogenetic Testing for Personalized Antiplatelet Therapy: Findings From the QPGx-CARES Initiative

Authors

Institutions

Publication Details

Journal
Clinical Therapeutics
Published
2025-12-26
DOI
https://doi.org/10.1016/j.clinthera.2025.12.003
Citations
1
Primary Topic
Antiplatelet Therapy and Cardiovascular Diseases
Type
article
Field-Weighted Citation Impact
1.39

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Implementing CYP2C19 Pharmacogenetic Testing for Personalized Antiplatelet Therapy: Findings From the QPGx-CARES Initiative

Jassim Al Suwaidi, Rania Abdellatif, Said I. Ismail, Shaban Mohammed et al.
1 citations
Clinical Therapeutics
Antiplatelet Therapy and Cardiovascular Diseases
1.39
article

Implementing CYP2C19 Pharmacogenetic Testing for Personalized Antiplatelet Therapy: Findings From the QPGx-CARES Initiative

Jassim Al Suwaidi, Rania Abdellatif, Said I. Ismail, Shaban Mohammed, Abdul rahman Arabi, Daoud Al-Badriyeh, Wadha Al Muftah, Toka AlHsson, Awad Al-Qahtani, Radja Badji, Moza Al Hail
article en
1 citations

Abstract

No abstract available for this paper.
Clinical TherapeuticsVol. 48(2)
Hamad Medical Corporation (QA), Qatar University (QA), Qatar Foundation (QA)
Medical Research Council
Openalex Percentile: Top 12%
Antiplatelet Therapy and Cardiovascular Diseases
1.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.